| abstract |
A compound of Formula (I) or a pharmaceutically acceptable ester, amide, solvate, or salt thereof, or a salt of such an ester or amide or a solvate of such an ester amide or salt wherein the definitions of R 1 -R 13 and L 1 -L 4 are provided in the disclosure, and wherein R 14 is a group capable of binding to prostate-specific membrane antigen (PSMA). |